Name | 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid,3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine |
---|---|
Synonyms |
Imipramine pamoate
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-,pamoate Tofranil-pm (TN) 4,4'-methylenebis(3-hydroxy-2-naphthoic) acid,compound with 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propylamine (1:2) 2-Naphthalenecarboxylic acid,4,4'-methylenebis(3-hydroxy-,compd. with 10,11-dihydro-N,N-dimethyl-5H-dibenz(b,f)azepine-5-propanamine (1:2) Imipramine embonate EINECS 233-206-6 |
Description | Imipramine pamoate is a potent anti-depressant compound[1][2]. |
---|---|
Related Catalog | |
References |
[1]. Doyle LN. Imipramine pamoate in depression. Psychosomatics. 1975;16(3):129-31. |
Boiling Point | 642.7ºC at 760 mmHg |
---|---|
Molecular Formula | C61H64N4O6 |
Molecular Weight | 949.18400 |
Flash Point | 356.5ºC |
Exact Mass | 948.48300 |
PSA | 128.02000 |
LogP | 12.27140 |
Vapour Pressure | 2.13E-17mmHg at 25°C |
~58% 10075-24-8 |
Literature: King, Clifford Riley; D'Ambrosio, Stephen G.; Bristol, David W. Patent: US2012/28960 A1, 2012 ; Location in patent: Page/Page column 26 ; |
~% 10075-24-8 |
Literature: US7718649 B1, ; |
~% 10075-24-8 |
Literature: US2012/28960 A1, ; |